deltatrials
Unknown OBSERVATIONAL NCT04882189

Study of Endothelial Cell Condition After Cataract Surgery Performed Using Capsulorhexis or ZEPTO (ZEPTO)

A Prospective Randomized Controlled Masked Study of Endothelial Cell Condition After Cataract Surgery Performed Using Manual Capsulorhexis or the ZEPTO Precision Capsulotomy System

Sponsor: Centricity Vision, Inc.

Conditions Endothelial Cell Density Loss
Interventions Imaging
Updated 5 times since 2021 Last updated: Mar 8, 2022 Started: Aug 23, 2021 Primary completion: Mar 30, 2022 Completion: May 30, 2022
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Endothelial Cell Density Loss, this trial is ongoing. The trial is conducted by Centricity Vision, Inc. and has accumulated 5 data snapshots since 2021. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Jun 2021 – ~Apr 2022 · 10 months · monthly snapshotNot Yet Recruiting~Apr 2022 – ~Apr 2024 · 24 months · monthly snapshotRecruiting~Apr 2024 – ~Jul 2024 · 3 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 23 months · monthly snapshotUnknown

Change History

5 versions recorded

  1. Sep 2024 — Present [monthly]

    Unknown

  2. Jul 2024 — Sep 2024 [monthly]

    Unknown

    Status: Unknown Status → Unknown

  3. Apr 2024 — Jul 2024 [monthly]

    Unknown Status

    Status: Recruiting → Unknown Status

  4. Apr 2022 — Apr 2024 [monthly]

    Recruiting

    Status: Not Yet Recruiting → Recruiting

  5. Jun 2021 — Apr 2022 [monthly]

    Not Yet Recruiting

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Centricity Vision, Inc.
Data source: Centricity Vision, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations